BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31568687)

  • 41. Variants in the FTO and CDKAL1 loci have recessive effects on risk of obesity and type 2 diabetes, respectively.
    Wood AR; Tyrrell J; Beaumont R; Jones SE; Tuke MA; Ruth KS; ; Yaghootkar H; Freathy RM; Murray A; Frayling TM; Weedon MN
    Diabetologia; 2016 Jun; 59(6):1214-21. PubMed ID: 26961502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined effects of MC4R and FTO common genetic variants on obesity in European general populations.
    Cauchi S; Stutzmann F; Cavalcanti-Proença C; Durand E; Pouta A; Hartikainen AL; Marre M; Vol S; Tammelin T; Laitinen J; Gonzalez-Izquierdo A; Blakemore AI; Elliott P; Meyre D; Balkau B; Järvelin MR; Froguel P
    J Mol Med (Berl); 2009 May; 87(5):537-46. PubMed ID: 19255736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome.
    Brower MA; Hai Y; Jones MR; Guo X; Chen YI; Rotter JI; Krauss RM; Legro RS; Azziz R; Goodarzi MO
    Hum Reprod; 2019 Jan; 34(1):127-136. PubMed ID: 30496407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FTO gene SNPs associated with extreme obesity in cases, controls and extremely discordant sister pairs.
    Price RA; Li WD; Zhao H
    BMC Med Genet; 2008 Jan; 9():4. PubMed ID: 18218107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of single nucleotide polymorphism (rs741301) of the ELMO1 gene with diabetic kidney disease in Polish patients with type 2 diabetes: a pilot study.
    Kwiendacz H; Nabrdalik K; Adamczyk P; Moczulski D; Moczulska H; Trautsolt W; Górczyńska-Kosiorz S; Grzeszczak W; Gumprecht J
    Endokrynol Pol; 2020; 71(1):66-72. PubMed ID: 31909452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macronutrient intake as a mediator with FTO to increase body mass index.
    Hardy DS; Racette SB; Hoelscher DM
    J Am Coll Nutr; 2014; 33(4):256-66. PubMed ID: 25144299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between
    Zhao H; Ma L; Yan M; Wang Y; Zhao T; Zhang H; Liu P; Liu Y; Li P
    J Diabetes Res; 2018; 2018():5068578. PubMed ID: 29862302
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FTO haplotyping underlines high obesity risk for European populations.
    Babenko V; Babenko R; Gamieldien J; Markel A
    BMC Med Genomics; 2019 Mar; 12(Suppl 2):46. PubMed ID: 30871540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of fat mass and obesity-associated and retinitis pigmentosa guanosine triphosphatase (GTPase) regulator-interacting protein-1 like polymorphisms with body mass index in Chinese women.
    Chen B; Li Z; Chen J; Ji J; Shen J; Xu Y; Zhao Y; Liu D; Shen Y; Zhang W; Shen J; Wang Y; Shi Y
    Endocr J; 2018 Jul; 65(7):783-791. PubMed ID: 29657248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A genome-wide association study identifies a possible role for cannabinoid signalling in the pathogenesis of diabetic kidney disease.
    Osman W; Mousa M; Albreiki M; Baalfaqih Z; Daggag H; Hill C; McKnight AJ; Maxwell AP; Al Safar H
    Sci Rep; 2023 Mar; 13(1):4661. PubMed ID: 36949158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gender-Dependent Association of FTO Polymorphisms with Body Mass Index in Mexicans.
    Saldaña-Alvarez Y; Salas-Martínez MG; García-Ortiz H; Luckie-Duque A; García-Cárdenas G; Vicenteño-Ayala H; Cordova EJ; Esparza-Aguilar M; Contreras-Cubas C; Carnevale A; Chávez-Saldaña M; Orozco L
    PLoS One; 2016; 11(1):e0145984. PubMed ID: 26726774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.
    Sigurdson AJ; Brenner AV; Roach JA; Goudeva L; Müller JA; Nerlich K; Reiners C; Schwab R; Pfeiffer L; Waldenberger M; Braganza M; Xu L; Sturgis EM; Yeager M; Chanock SJ; Pfeiffer RM; Abend M; Port M
    Carcinogenesis; 2016 Jul; 37(7):677-684. PubMed ID: 27207655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of the Impact of Common Polymorphisms of the FTO and MC4R Genes with the Risk of Severe Obesity in Saudi Arabian Population.
    Cyrus C; Ismail MH; Chathoth S; Vatte C; Hasen M; Al Ali A
    Genet Test Mol Biomarkers; 2018 Mar; 22(3):170-177. PubMed ID: 29466028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between LEPR, FTO, MC4R, and PPARG-2 polymorphisms with obesity traits and metabolic phenotypes in school-aged children.
    Almeida SM; Furtado JM; Mascarenhas P; Ferraz ME; Ferreira JC; Monteiro MP; Vilanova M; Ferraz FP
    Endocrine; 2018 Jun; 60(3):466-478. PubMed ID: 29679223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of type 2 diabetes and obesity is differentially associated with variation in FTO in whites and African-Americans in the ARIC study.
    Bressler J; Kao WH; Pankow JS; Boerwinkle E
    PLoS One; 2010 May; 5(5):e10521. PubMed ID: 20502638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population.
    Lee YH; Kang ES; Kim SH; Han SJ; Kim CH; Kim HJ; Ahn CW; Cha BS; Nam M; Nam CM; Lee HC
    J Hum Genet; 2008; 53(11-12):991-998. PubMed ID: 18991055
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of KALRN, ADIPOQ, and FTO gene polymorphism in type 2 diabetic patients with coronary artery disease: possible predisposing markers.
    Mofarrah M; Ziaee S; Pilehvar-Soltanahmadi Y; Zarghami F; Boroumand M; Zarghami N
    Coron Artery Dis; 2016 Sep; 27(6):490-6. PubMed ID: 27218147
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Gu Z; Bi Y; Yuan F; Wang R; Li D; Wang J; Hu X; He G; Zhang L; Liu BC
    Clin Interv Aging; 2020; 15():1333-1341. PubMed ID: 32848374
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction analysis of
    Ruiz-Díaz MS; Mena-Yi D; Gómez-Camargo D; Mora-García G
    Colomb Med (Cali); 2022; 53(2):e2044874. PubMed ID: 36415696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FTO polymorphisms are associated with obesity but not diabetes risk in postmenopausal women.
    Song Y; You NC; Hsu YH; Howard BV; Langer RD; Manson JE; Nathan L; Niu T; F Tinker L; Liu S
    Obesity (Silver Spring); 2008 Nov; 16(11):2472-80. PubMed ID: 18787525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.